Tag: Aridis Pharmaceuticals Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready ...

Added to Collection on: 2021-07-19 12:22:30

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Healthcare-associated infections
Immunology
Infectious diseases
Gram-positive bacteria
Pathogenic bacteria
Staphylococcus aureus
Monoclonal antibody
Antibiotic
Hospital-acquired pneumonia
Aridis Pharmaceuticals Inc.
AR-301
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Aridis In-Licenses Pneumonia Candidate From AstraZeneca

Added to Collection on: 2021-07-19 13:52:30

Tags for this article:

Health sciences
Drugs
Health care
AstraZeneca
Medical research
Södertälje Municipality
AZN
Oxford–AstraZeneca COVID-19 vaccine
Durvalumab
Zeneca
NASDAQ
AstraZeneca plc
Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Aridis Pharmaceuticals' COVID mAb Ranks Among the Top 5 Most Potent COVID-19 mAbs ...

Added to Collection on: 2021-07-26 12:22:30

Tags for this article:

Medical specialties
Health
Medicine
Sarbecovirus
Atypical pneumonias
Occupational safety and health
Immunology
Antibodies
Monoclonal antibody
Ventilator-associated pneumonia
Neutralizing antibody
Severe acute respiratory syndrome
Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Aridis Pharmaceuticals Announces Second Quarter 2021 Results

Added to Collection on: 2021-08-12 12:56:15

Tags for this article:

Health
Medical specialties
Medicine
Clinical trials
Medical research
Adenoviridae
Vaccine controversies
Oxford–AstraZeneca COVID-19 vaccine
Ventilator-associated pneumonia
AstraZeneca
Staphylococcus aureus
COVID-19 pandemic
Aridis Pharmaceuticals Inc.
AR-301

Click the tags to see associated articles and topics

View Article Details
Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is ... - PR Newswire

Added to Collection on: 2022-08-10 18:32:15

Tags for this article:

Medical specialties
Medicine
Health
Biotechnology
Pneumonia
Immunology
Zoonoses
Immune system
Monoclonal antibody
Severe acute respiratory syndrome–related coronavirus
Severe acute respiratory syndrome
Coronavirus
Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Aridis Pharmaceuticals (NASDAQ:ARDS) Stock Rating Reaffirmed by Maxim Group

Added to Collection on: 2022-08-18 07:47:30

Tags for this article:

Price?earnings ratio
Life Sciences
Biotechnology
Articles
Specialty drugs
Aridis Pharmaceuticals Inc.
aridis pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases

Added to Collection on: 2022-11-23 02:53:16

Tags for this article:

Medical specialties
Medicine
Bacteria
Pneumonia
RTT
Infectious diseases
Healthcare-associated infections
Respiratory therapy
Ventilator-associated pneumonia
Staphylococcus aureus
Pseudomonas aeruginosa
Cystic fibrosis
Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
FY2022 EPS Estimates for Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Decreased by Analyst

Added to Collection on: 2022-11-28 06:19:52

Tags for this article:

Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan ... - Yahoo Finance

Added to Collection on: 2022-12-05 12:21:48

Tags for this article:

Infectious diseases
Medicine
Medical specialties
Tropical diseases
Biological weapons
Zoonoses
Zaire ebolavirus
Ebola virus disease
Ebolavirus
Monoclonal antibody
Marburg virus disease
Sudan ebolavirus
Aridis Pharmaceuticals Inc.
Mapp Biopharmaceutical Inc.
Mab

Click the tags to see associated articles and topics

View Article Details
ARIDIS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement ... - MarketScreener

Added to Collection on: 2022-12-12 14:21:30

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Corporate finance
73rd United States Congress
Securities Act
U.S. Securities and Exchange Commission
Security
Repurchase agreement
Stock
Regulation S-K
Aridis Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details